2022
DOI: 10.1016/j.carbpol.2022.119833
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 47 publications
(25 citation statements)
references
References 33 publications
0
25
0
Order By: Relevance
“…Thiolation of eudragit S-100 was performed using l -cysteine by following the protocol as mentioned by Sood et al with slight modification. 13 Briefly, EU, EDC, and NHS (10 : 1 : 1 w/w) were mixed and added to l -cysteine in water with an EU : l -cysteine ratio of 2 : 1 (w/w). Afterward, the sample was stirred for 3 h at pH 6.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations
“…Thiolation of eudragit S-100 was performed using l -cysteine by following the protocol as mentioned by Sood et al with slight modification. 13 Briefly, EU, EDC, and NHS (10 : 1 : 1 w/w) were mixed and added to l -cysteine in water with an EU : l -cysteine ratio of 2 : 1 (w/w). Afterward, the sample was stirred for 3 h at pH 6.…”
Section: Methodsmentioning
confidence: 99%
“…7–12 However, their successful commercial application is still limited due to the lack of cytotoxic specificity, and the complex biological conditions of the gastrointestinal tract. 13,14…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…In an investigation performed by Sood et al., [ 204 ] biodegradable disulfide (SS) crosslinked chitosan‐stearic acid NPs (approximately 200 nm) were fabricated for dual drug (hydrophobic curcumin and hydrophilic DOX) delivery for colorectal cancer. The combination of DOX with a natural anticancer agent in a single formulation displayed different mode of anticancer action, developing a system for cancer therapy with improved efficacy.…”
Section: Improved Bioavailability Controlled Release and Anticancer A...mentioning
confidence: 99%